Director and research team for UTRGV South Texas Diabetes and Obesity Institute to be announced Monday

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Two news conferences will be held Monday morning to announce that Dr. Sarah Williams-Blangero, a nationally renowned genetics and infectious disease expert, will be the inaugural director of the UTRGV South Texas Diabetes and Obesity Institute.

In addition, Dr. Williams-Blangero, former chair of the department of genetics at the Texas Biomedical Research Institute in San Antonio, is bringing a 22-person team of expert researchers and support staff with her to UTRGV.

The first news conference will take place at 9 a.m. in Salon Cassia at UT Brownsville’s Main (formerly the Education and Business Complex) and will be webcast live at media.utb.edu/live.aspx. The second news conference will begin at 11:15 a.m. in UT Pan American’s University Ballroom and will be webcast live at UTPA.edu/LIVE.

- Advertisement -

Both events will include remarks from Dr. Williams-Blangero; Chancellor Francisco G. Cigarroa, M.D.; Guy Bailey, founding president of UT Rio Grande Valley; and Francisco Fernandez, M.D., founding dean of the UTRGV School of Medicine.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

DSHS Confirms First West Nile Case in Texas in 2026

The Texas Department of State Health Services is reporting this year’s first case of West Nile illness in a resident of Harris County. Health officials confirmed the resident was diagnosed with West Nile virus neuroinvasive disease. 

Spanish researchers eliminate pancreatic tumors in mice using a three-drug therapy

A team of scientists at the Centro Nacional de Investigaciones Oncológicas (CNIO) has reported the complete elimination of pancreatic tumors in mice using a combination of three targeted drugs.

Ivermectin Access Expands Under New State Law

Mega Doctor News Mega Doctor News Texas has enacted House Bill 25 (HB...
- Advertisement -